Lind
Intelligent Research Platform for Health Systems
San Francisco · $5.5M raised
- Headquarters
- San Francisco
- Business Model
- B2B
- Website
- lind.care
- Total Funding
- $5.5M
- Last Round
- $5.5M SeedJan 2026
- Rounds
- 1
About
Lind is an AI-powered clinical trial screening and matching platform built for health systems rather than pharmaceutical sponsors. The platform screens every patient against every open study nightly, using EHR-native data to surface matches with clinical evidence already mapped to eligibility criteria, helping trial coordinators identify candidates without adding to their workload. Founded by CEO Ognjen "Oggie" Nikolic (ex-Google, GRAIL) and CTO Pranav Singh (ex-Illumina, GRAIL, Upstart), Lind is based in San Francisco and raised a $5.5 million seed round in December 2023 led by 8VC, Abstract Ventures, and Correlation Ventures.
Summary
Lind is an Artificial Intelligence company based in San Francisco. It has raised $5.5M in total across 1 round, most recently a $5.5M Seed round in Jan 2026. Investors include 8VC, Abstract Ventures and Correlation Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
